Phaco Training: Debra A. Goldstein M.D. Speaks on Biologics for Ocular Inflamamtion
Biologics may be useful for ocular inflammation November 14, 2019 SAN FRANCISCO — Only adalimumab is FDA-approved for the treatment of noninfectious intermediate and posterior uveitis and panuveitis; however, other biologics hold promise for the treatment of ocular inflammation, according to a presentation at Cornea Subspecialty Day at the American Academy of Ophthalmology annual meeting.… Read More »